Cargando…

Heterogeneity of the tumor immune microenvironment and its clinical relevance

During the course of tumorigenesis and subsequent metastasis, malignant cells gradually diversify and become more heterogeneous. Consequently, the tumor mass might be infiltrated by diverse immune-related components, including the cytokine/chemokine environment, cytotoxic activity, or immunosuppress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Qingzhu, Wang, Aoyun, Yuan, Yixiao, Zhu, Bo, Long, Haixia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034473/ https://www.ncbi.nlm.nih.gov/pubmed/35461288 http://dx.doi.org/10.1186/s40164-022-00277-y

Ejemplares similares

Somatostatin Receptor 2: A Potential Predictive Biomarker for Immune Checkpoint Inhibitor Treatment
por: Wang, Aoyun, et al.
Publicado: (2022)

ENPEP as a potential predictor of immune checkpoint inhibitor efficacy
por: Wang, Aoyun, et al.
Publicado: (2021)

Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2016)

Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location
por: Zhang, Longhui, et al.
Publicado: (2018)

Programmed Cell Death Protein Ligand 2 Is a Potential Biomarker That Predicts the Efficacy of Immunotherapy
por: Wang, Aoyun, et al.
Publicado: (2021)

Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy
por: Yuan, Ting, et al.
Publicado: (2023)

Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
por: Aboelella, Nada S., et al.
Publicado: (2021)

Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
por: Galli, Filippo, et al.
Publicado: (2020)

Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies
por: Xu, Yashi, et al.
Publicado: (2023)

Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
por: Qin, Yixiao, et al.
Publicado: (2021)

Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
por: Komuta, Mina
Publicado: (2022)

Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer
por: Shinkawa, Tomohiko, et al.
Publicado: (2022)

The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis
por: Roberts, Cai M., et al.
Publicado: (2019)

Cellular heterogeneity map of diverse immune and stromal phenotypes within breast tumor microenvironment
por: Li, Yuan, et al.
Publicado: (2020)

High-throughput single-сell sequencing in cancer research
por: Jia, Qingzhu, et al.
Publicado: (2022)

Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study
por: Gao, Yue, et al.
Publicado: (2020)

Cancer-Associated Fibroblast Heterogeneity and Its Influence on the Extracellular Matrix and the Tumor Microenvironment
por: Knipper, Karl, et al.
Publicado: (2023)

Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer
por: Yu, Lan, et al.
Publicado: (2021)

Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance
por: Zhang, Aiping, et al.
Publicado: (2022)

Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling
por: Li, Ning, et al.
Publicado: (2023)

Correction to: Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
por: Eckert, Alexander W., et al.
Publicado: (2018)

Overview on Clinical Relevance of Intra-Tumor Heterogeneity
por: Stanta, Giorgio, et al.
Publicado: (2018)

Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer
por: Feng, Yi, et al.
Publicado: (2018)

Metabolic heterogeneity and immunocompetence of infiltrating immune cells in the breast cancer microenvironment
por: Chen, Hongdan, et al.
Publicado: (2021)

Intratumoral microbial heterogeneity affected tumor immune microenvironment and determined clinical outcome of HBV-related HCC
por: Li, Shengnan, et al.
Publicado: (2023)

The modulation relationship of genomic pattern of intratumor heterogeneity and immunity microenvironment heterogeneity in hepatocellular carcinoma
por: Li, Liu-Bo, et al.
Publicado: (2020)

Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity
por: Albini, Adriana, et al.
Publicado: (2015)

Targeting Endocytosis and Cell Communications in the Tumor Immune Microenvironment
por: Wu, Bo, et al.
Publicado: (2022)

Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment
por: Ma, Guofeng, et al.
Publicado: (2022)

Metabolism drives macrophage heterogeneity in the tumor microenvironment
por: Li, Shasha, et al.
Publicado: (2022)

Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application
por: Pu, Feifei, et al.
Publicado: (2021)

Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma
por: Li, Chao, et al.
Publicado: (2022)

Pyroptosis, metabolism, and tumor immune microenvironment
por: Du, Tiantian, et al.
Publicado: (2021)

Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness
por: Hass, Ralf, et al.
Publicado: (2020)

Future of immune checkpoint inhibitors: focus on tumor immune microenvironment
por: Jia, Yunlong, et al.
Publicado: (2020)

Cytokine-Induced Senescence in the Tumor Microenvironment and Its Effects on Anti-Tumor Immune Responses
por: Rentschler, Maximilian, et al.
Publicado: (2022)

Unraveling Heterogeneity of Tumor Cells and Microenvironment and Its Clinical Implications for Triple Negative Breast Cancer
por: Jiang, Ke, et al.
Publicado: (2021)

Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset
por: Agnoletto, Chiara, et al.
Publicado: (2019)

The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?
por: Ma, Jiayao, et al.
Publicado: (2021)

Role of the tumor immune microenvironment in tumor immunotherapy
por: Zhou, Changsheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s1k18llht0dk8195eloguq9p7h